Soleno Therapeutics Inc (SLNO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
49.11 +0.71 (+1.47%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 49.11 unch (unch) 16:55 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 187,671 | 41,384 | 24,397 | 31,528 | 36,289 |
| Operating Income | -187,671 | -41,384 | -24,397 | -31,528 | -36,289 |
| Interest Expense | 231 | 0 | 0 | 0 | 0 |
| Other Income | 12,052 | 2,396 | 330 | 618 | 11,650 |
| Pre-tax Income | -175,850 | -38,988 | -24,067 | -30,910 | -24,639 |
| Net Income Continuous | -175,850 | -38,988 | -24,067 | -30,910 | -24,639 |
| Net Income | $-175,850 | $-38,988 | $-24,067 | $-30,910 | $-24,639 |
| EPS Basic Total Ops | -4.38 | -2.36 | -2.87 | -5.81 | -5.85 |
| EPS Basic Continuous Ops | -4.38 | -2.36 | -2.87 | -5.81 | -5.90 |
| EPS Diluted Total Ops | -4.38 | -2.36 | -2.87 | -5.81 | -5.85 |
| EPS Diluted Continuous Ops | -4.38 | -2.36 | -2.87 | -5.81 | -5.90 |
| EPS Diluted Before Non-Recurring Items | -4.38 | -2.36 | -2.87 | -6.00 | -5.85 |
| EBITDA(a) | $-185,684 | $-39,426 | $-22,433 | $-29,565 | $-34,335 |